SEC 13F Intelligence

5am Venture Management, LLC / ELVN

5am Venture Management, LLC’s Enliven Therapeutics Inc Position

Does 5am Venture Management, LLC own Enliven Therapeutics Inc (ELVN)? Not currently — the last reported position was 772.5K shares worth $12M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$12M
Q4 2025
Shares
772.5K
% of Portfolio
+3.74%
Quarters Held
12
position exited

Position History ELVN

Reported value by quarter
Q1 ’23: $127MQ1 ’23Q2 ’23: $118MQ3 ’23: $70MQ3 ’23Q4 ’23: $71MQ1 ’24: $67MQ1 ’24Q2 ’24: $61MQ3 ’24: $45MQ3 ’24Q4 ’24: $37MQ1 ’25: $26MQ1 ’25Q2 ’25: $15MQ3 ’25: $16MQ3 ’25Q4 ’25: $12Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 2025772.5K$12M+3.74%
Q3 2025772.5K$16M+5.79%
Q2 2025772.5K$15M+5.96%
Q1 20251.32M$26M+9.84%
Q4 20241.63M$37M+8.75%
Q3 20241.75M$45M+9.25%
Q2 20242.61M$61M+13.65%
Q1 20243.84M$67M+15.11%
Q4 20235.16M$71M+18.95%
Q3 20235.16M$70M+20.29%
Q2 20235.80M$118M+29.48%
Q1 20235.80M$127M+32.47%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See 5am Venture Management, LLC’s full portfolio or all institutional holders of ELVN.